Search

everythinglearnresearchcommunity

for

Search:↓

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Mice with autoimmune hair loss showed signs of heart problems.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Early balding at 40 increases prostate cancer risk.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Adolescents with severe alopecia incur significantly higher healthcare costs.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.